Celltrion
068270.KS
#681
Rank
โ‚น3.390 T
Marketcap
โ‚น14,870
Share price
-0.47%
Change (1 day)
40.52%
Change (1 year)
Celltrion is a Korean pharmaceutical company headquartered in Incheon, South Korea. Celltrion Healthcare conducts worldwide marketing, sales, and distribution of biological medicines developed by Celltrion.

EPS for Celltrion (068270.KS)

EPS in 2023 (TTM): โ‚น245.23

According to Celltrion 's latest financial reports the company's current EPS (TTM) is โ‚น305.56. In 2022 the company made an earnings per share (EPS) of โ‚น273.11 a decrease over its 2021 EPS that were of โ‚น324.51.

EPS history for Celltrion from 2007 to 2023

Annual EPS

Year EPS Change
2023 (TTM)โ‚น245.23-10.21%
2022โ‚น273.11-15.84%
2021โ‚น324.5112.77%
2020โ‚น287.7670.79%
2019โ‚น168.4915.63%
2018โ‚น145.71-33.13%
2017โ‚น217.92141.17%
2016โ‚น90.368.28%
2015โ‚น83.4511.28%
2014โ‚น74.9916.37%
2013โ‚น64.44-67.42%
2012โ‚น197.8284.22%
2011โ‚น107.3862.13%
2010โ‚น66.2380.61%
2009โ‚น36.67-559.63%
2008-โ‚น7.98-123.16%
2007โ‚น34.45